Price
1D
5D
1M
6M
YTD
1Y
5Y
▤ Line ▾
⏱ 2m ▾
∿ Studies 0 ▾
⇄ Compare ▾
✎ Draw 0 ▾
EXT
%
LOG
⟲
⛶
Chart style ✕
Chart style
Line Area
Candles OHLC bars
Interval ✕
Interval
1 min 2 min
5 min 15 min
30 min 1 hour
1 day 1 week
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Studies ✕
Overlays
SMA 20 SMA 50
SMA 200 EMA 21
Bollinger VWAP
Session levels
Prior day H/L/C
Opening range
Volume profile
Lower pane
Volume
RSI 14 MACD
Compare ✕
Overlay another symbol
SPY QQQ
IWM DIA
Add
Remove comparison
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Drawing tools ✕
Tool
Cursor Trend line
Price level Zone
Measure
Clear all drawings
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Trailing performance Price return · vs SPY
Return vs SPY
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on 185.DE open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals TTM · reported
Market cap —
Enterprise value —
Revenue (TTM) —
Gross profit —
EBITDA —
Net income —
EPS (TTM) —
Free cash flow —
Total cash —
Total debt —
Book value / share —
Shares outstanding —
Float —
Short % of float —
Dividend yield —
Beta (5Y) —
Valuation & profitability ratios Account required
Trailing P/E —
Forward P/E —
PEG ratio —
Price / sales —
Price / book —
EV / revenue —
EV / EBITDA —
Gross margin —
Operating margin —
Profit margin —
Return on equity —
Return on assets —
Debt / equity —
Current ratio —
Free account required
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements As reported · 5 years · 6 quarters
Income Balance sheet Cash flow
Annual Quarterly
Blank means not reported, not zero
Line item 2025 2024 2023 2022 YoY
Total revenue
$12.83B $11.89B $10.55B $12.45B
+7.9%
Operating revenue
$12.83B $11.89B $10.55B $12.45B
+7.9%
Cost of revenue
$10.66B $10.04B $9.81B $10.21B
+6.1%
Gross profit
$2.17B $1.85B $738.00M $2.24B
+17.4%
Research & development
$24.00M $57.00M $39.00M $32.00M
-57.9%
Selling, general & admin
$299.00M $275.00M $226.00M $204.00M
+8.7%
Total operating expense
$1.42B $1.02B $965.00M $908.00M
+38.3%
Operating income
$758.00M $828.00M -$227.00M $1.33B
-8.5%
Net interest income
-$158.00M -$156.00M -$107.00M -$106.00M
-1.3%
Pre-tax income
$1.06B $289.00M -$584.00M $702.00M
+268.2%
Tax provision
-$55.00M $265.00M $189.00M $664.00M
-120.8%
Net income
$1.16B $60.00M -$651.00M -$123.00M
+1,828.3%
Net income to common
$1.16B $60.00M -$651.00M -$123.00M
+1,828.3%
Basic EPS
4.45 0.26 -3.65 -0.57
+1,611.5%
Diluted EPS
4.42 0.26 -3.65 -0.57
+1,600.0%
EBIT
$1.22B $445.00M -$477.00M $808.00M
+174.6%
EBITDA
$1.84B $1.09B $155.00M $1.43B
+69.7%
Basic shares
259.38M 212.42M 178.31M 180.65M
+22.1%
Diluted shares
261.20M 214.05M 178.31M 180.65M
+22.0%
Line item 2025 2024 2023 2022 YoY
Cash & equivalents
$1.60B $1.14B $944.00M $1.36B
+40.3%
Cash & short-term investments
$1.60B $1.14B $944.00M $1.36B
+40.3%
Accounts receivable
$1.06B $1.10B $656.00M $778.00M
-2.9%
Inventory
$2.18B $2.00B $2.16B $2.43B
+9.0%
Total current assets
$5.47B $4.91B $4.41B $5.25B
+11.3%
Property, plant & equipment
$6.70B $6.39B $6.79B $6.49B
+4.9%
Goodwill & intangibles
$34.00M $178.00M $183.00M $174.00M
-80.9%
Total assets
$16.13B $14.06B $14.15B $14.76B
+14.7%
Total current liabilities
$3.80B $3.40B $3.03B $3.00B
+12.0%
Current debt
$10.00M $125.00M $135.00M $1.00M
-92.0%
Long-term debt
$2.44B $2.47B $1.73B $1.81B
-1.3%
Total debt
$2.71B $2.82B $1.97B $1.87B
-3.9%
Total liabilities
$9.94B $8.91B $8.31B $8.17B
+11.5%
Retained earnings
-$271.00M -$1.32B -$1.29B -$570.00M
+79.5%
Shareholder equity
$6.12B $5.16B $4.25B $5.08B
+18.6%
Working capital
$1.67B $1.52B $1.38B $2.25B
+9.8%
Net tangible assets
$6.08B $4.98B $4.07B $4.90B
+22.2%
Shares issued
263.10M 258.36M 178.47M 176.97M
+1.8%
Line item 2025 2024 2023 2022 2021 YoY
Net income
$1.12B $24.00M -$773.00M $38.00M —
+4,562.5%
Depreciation & amortisation
$623.00M $642.00M $632.00M $617.00M —
-3.0%
Stock-based compensation
$41.00M $36.00M $35.00M $40.00M —
+13.9%
Change in working capital
-$456.00M -$499.00M -$270.00M -$848.00M —
+8.6%
Operating cash flow
$1.19B $622.00M $91.00M $822.00M —
+90.5%
Capital expenditure
-$618.00M -$580.00M -$531.00M -$480.00M —
-6.6%
Investing cash flow
-$502.00M -$608.00M -$585.00M -$495.00M —
+17.4%
Share buybacks
— $0 $0 -$500.00M -$150.00M
—
Dividends paid
-$105.00M -$90.00M -$72.00M -$72.00M —
-16.7%
Financing cash flow
-$261.00M $201.00M $57.00M -$768.00M —
-229.9%
Free cash flow
$567.00M $42.00M -$440.00M $342.00M —
+1,250.0%
End cash position
$1.69B $1.23B $1.05B $1.47B —
+37.1%
Line item 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 YoY
Total revenue
$3.97B $3.19B $3.45B $3.00B $3.02B —
+24.2%
Operating revenue
$3.97B $3.19B $3.45B $3.00B $3.02B —
+24.2%
Cost of revenue
$2.97B $2.51B $2.87B $2.69B $2.65B —
+18.1%
Gross profit
$999.00M $681.00M $576.00M $300.00M $366.00M —
+46.7%
Research & development
$11.00M $10.00M -$11.00M $11.00M $12.00M —
+10.0%
Selling, general & admin
$101.00M $83.00M $68.00M $78.00M $82.00M —
+21.7%
Total operating expense
$285.00M $255.00M $688.00M $249.00M $247.00M —
+11.8%
Operating income
$714.00M $426.00M -$112.00M $51.00M $119.00M —
+67.6%
Net interest income
-$36.00M -$35.00M -$16.00M -$33.00M -$56.00M —
-2.9%
Pre-tax income
$482.00M $499.00M $68.00M $167.00M $161.00M —
-3.4%
Tax provision
$73.00M $82.00M -$134.00M -$51.00M $10.00M —
-11.0%
Net income
$407.00M $425.00M $213.00M $232.00M $164.00M —
-4.2%
Net income to common
$407.00M $425.00M $213.00M $232.00M $164.00M —
-4.2%
Basic EPS
1.54 1.61 0.86 — 0.63 2.08
-4.3%
Diluted EPS
1.53 1.60 0.85 — 0.62 2.07
-4.4%
EBIT
$518.00M $534.00M $84.00M $200.00M $217.00M —
-3.0%
EBITDA
$691.00M $696.00M $246.00M $360.00M $370.00M —
-0.7%
Basic shares
263.89M 263.65M 260.93M 258.92M 258.90M —
+0.1%
Diluted shares
265.96M 265.69M 263.30M 260.89M 260.34M —
+0.1%
Line item 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 YoY
Cash & equivalents
$1.35B $1.35B $1.60B $1.49B $1.51B
-0.1%
Cash & short-term investments
$1.35B $1.35B $1.60B $1.49B $1.51B
-0.1%
Accounts receivable
$1.54B $1.19B $1.06B $1.04B $979.00M
+29.0%
Inventory
$2.34B $2.30B $2.18B $2.19B $2.22B
+1.9%
Total current assets
$5.88B $5.68B $5.47B $5.28B $5.40B
+3.6%
Property, plant & equipment
$6.90B $6.86B $6.70B $6.63B $6.67B
+0.6%
Goodwill & intangibles
$33.00M $34.00M $34.00M $179.00M $178.00M
-2.9%
Total assets
$16.85B $16.64B $16.13B $15.97B $14.99B
+1.3%
Total current liabilities
$3.83B $3.83B $3.80B $3.39B $3.27B
+0.2%
Current debt
$1.00M $110.00M $10.00M $3.00M $83.00M
-99.1%
Long-term debt
$2.22B $2.44B $2.44B $2.58B $2.57B
-8.9%
Total debt
$2.23B $2.55B $2.71B $2.58B $2.66B
-12.8%
Total liabilities
$9.42B $9.75B $9.94B $9.54B $8.76B
-3.4%
Retained earnings
$508.00M $127.00M -$271.00M -$458.00M -$664.00M
+300.0%
Shareholder equity
$7.37B $6.83B $6.12B $6.34B $6.13B
+8.0%
Working capital
$2.05B $1.85B $1.67B $1.90B $2.13B
+10.7%
Net tangible assets
$7.34B $6.79B $6.08B $6.17B $5.96B
+8.0%
Shares issued
263.89M 263.10M 263.10M 258.36M 258.36M
+0.3%
Line item 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 YoY
Net income
$409.00M $417.00M $202.00M $218.00M $151.00M
-1.9%
Depreciation & amortisation
$173.00M $162.00M $162.00M $160.00M $153.00M
+6.8%
Stock-based compensation
$17.00M $13.00M $8.00M $10.00M $12.00M
+30.8%
Change in working capital
-$65.00M -$792.00M -$30.00M $85.00M $193.00M
+91.8%
Operating cash flow
$608.00M -$179.00M $537.00M $85.00M $488.00M
+439.7%
Capital expenditure
-$186.00M -$119.00M -$243.00M -$151.00M -$131.00M
-56.3%
Investing cash flow
-$203.00M -$129.00M -$251.00M -$11.00M -$132.00M
-57.4%
Dividends paid
-$26.00M -$27.00M -$26.00M -$26.00M -$27.00M
+3.7%
Financing cash flow
-$353.00M $60.00M -$166.00M -$105.00M -$67.00M
-688.3%
Free cash flow
$422.00M -$298.00M $294.00M -$66.00M $357.00M
+241.6%
End cash position
$1.49B $1.45B $1.69B $1.57B $1.60B
+3.2%
Analyst targets & ownership Account required
Mean target —
High target —
Low target —
Implied upside —
Analyst count —
Consensus —
Strong buy / Buy — / —
Hold —
Sell / Strong sell — / —
Held by insiders —
Held by institutions —
Institutions holding —
Free account required
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals Computed from 2Y daily closes
SMA 10
44.05
+1.74% from price
SMA 20
41.90
+6.96% from price
SMA 50
43.70
+2.55% from price
SMA 100
51.50
-12.97% from price
SMA 200
49.03
-8.58% from price
EMA 12
43.24
+3.66% from price
EMA 26
43.04
+4.13% from price
EMA 50
44.97
-0.33% from price
MACD (12,26,9)
0.20
Hist 0.46
ATR (14)
1.67
3.73% of price
Realised vol 30D
44.6%
Annualised
Bollinger upper
47.05
20, 2σ
Bollinger lower
36.75
20, 2σ
50 / 200 cross
Death
43.70 vs 49.03
Trend bias
Below 200
-8.58%
Options chain Account required
Expiry Loading… Spot 44.82
Calls Strike Last Bid Ask Vol OI IV
000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0%
Puts Strike Last Bid Ask Vol OI IV
000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0%
Free account required
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile Daily returns · 1Y window
Beta vs SPY
0.07
Less volatile than market
Correlation to SPY
0.02
Largely independent
Realised vol 30D
44.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-47.0%
Peak to trough
Max drawdown 5Y
-76.1%
Peak to trough
Beta (reported)
—
5Y monthly, from filing
Headlines 185.DE · links out to the publisher
Johnson & Johnson’s multiple myeloma treatment secures EC approval
Pharmaceutical Technology · 2m ago
Property Taxes Up $743.8 Million; Homeowners Hit Again
PR Newswire · 4m ago
Best high-yield savings interest rates today, Monday, August 24, 2026: Earn up to 4.15% APY
Yahoo Personal Finance · 4m ago
How Olipop is beating big soda at its own game: Fmr CEO
Yahoo Finance Video · 4m ago
HELOC and home equity loan rates today, Monday, August 24, 2026: A 19-basis-point differential
Yahoo Personal Finance · 4m ago
Best CD rates today, Monday, August 24, 2026: Lock in up to 4.35% APY
Yahoo Personal Finance · 4m ago
Mortgage and refinance rates today, Monday, August 24, 2026: Purchase and refi rates prove shopping matters
Yahoo Personal Finance · 4m ago
Travelodge Osaka Shinsaibashi Officially Opens, Marking a New Chapter for Travelodge Hotels Asia in Japan
ACCESS Newswire · 7m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.
Request the strategy overview